Alterity Therapeutics Limited (ASX:ATH)

Alterity Therapeutics Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 10, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Cap	87	62	16	11	24	5
Market Cap Growth	18.82%	293.22%	39.46%	-53.63%	441.93%	119.47%
Enterprise Value	37.9	29.15	3.24	-4.33	-10.28	-23.56
PE Ratio	-	-5.46	-0.87	-1.23	-2.78	-3.21
PB Ratio	1.60	1.47	1.15	0.50	0.69	0.15
P/TBV Ratio	0.00	1.03	0.80	0.50	0.69	1.21
P/FCF Ratio	-	-5.43	-1.25	-0.57	-1.97	-0.26
P/OCF Ratio	-	-5.43	-1.26	-0.57	-1.98	-0.26
EV/EBITDA Ratio	-	1.45	0.14	-0.23	-0.50	-1.20
EV/EBIT Ratio	-	1.45	0.14	-0.23	-0.50	-1.20
EV/FCF Ratio	-	-2.55	-0.26	0.22	0.83	1.36
Debt / Equity Ratio	0.00	0.00	0.00	0.00	0.00	0.00
Debt / EBITDA Ratio	0.01	0.01	0.01	0.01	0.01	0.00
Debt / FCF Ratio	-0.01	-0.01	-0.01	-0.01	-0.01	0.00
Net Debt / Equity Ratio	-0.90	-0.78	-0.90	-0.68	-0.98	-0.92
Net Debt / EBITDA Ratio	-3.10	-1.64	-0.53	-0.84	-1.68	-1.43
Net Debt / FCF Ratio	3.79	2.88	0.99	0.78	2.79	1.62
Quick Ratio	24.32	11.61	3.86	7.55	7.60	11.95
Current Ratio	21.98	12.98	3.54	6.17	7.07	10.92
Return on Equity (ROE)	-47.02%	-43.23%	-104.47%	-47.38%	-38.97%	-81.39%
Return on Assets (ROA)	47.38%	61.96%	101.77%	54.49%	55.34%	90.05%
Return on Invested Capital (ROIC)	496.81%	798.69%	2555.66%	4134.73%	-1321.71%	-1321.83%
Return on Capital Employed (ROCE)	50.97%	71.35%	128.45%	63.51%	62.44%	103.86%
Earnings Yield	-16.77%	-18.33%	-115.13%	-81.62%	-35.97%	-31.14%
FCF Yield	-	-18.40%	-79.71%	-176.66%	-50.78%	-384.03%
Buyback Yield / Dilution	-73.60%	-68.42%	-64.11%	-2.79%	-70.19%	-868.96%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.